---
category: news
title: "Biogen's lecanemab shows less cognitive decline with Alzheimer's, but more brain swelling"
excerpt: "Data showed that based on the Clinical Dementia Rating–Sum of Boxes (CDR-SB), an 18-point scale, those on lecanemab showed a cognitive decline an average of 1.21 points, compared to 1.66 points ..."
publishedDateTime: 2022-11-30T10:43:00Z
originalUrl: "https://seekingalpha.com/news/3912218-biogen-eisai-lecanemab-shows-less-cognitive-decline-with-alzheimers-but-more-brain-swelling"
webUrl: "https://seekingalpha.com/news/3912218-biogen-eisai-lecanemab-shows-less-cognitive-decline-with-alzheimers-but-more-brain-swelling"
type: article
quality: 30
heat: -1
published: false

provider:
  name: Seeking Alpha
  domain: seekingalpha.com

topics:
  - Microsoft AI
  - AI

images:
  - url: "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1356994685/image_1356994685.jpg?io=getty-c-w750"
    width: 750
    height: 417
    isCached: true

related:
  - title: "Alzheimer's drug trial shown to slow cognitive decline in long fight against dementia"
    excerpt: "Alzheimer's Research UK described the outcome as a \"major step forward\" in reducing cognitive decline among patients. \"These exciting findings represent a major step forward for dementia research ..."
    publishedDateTime: 2022-11-30T20:49:00Z
    webUrl: "https://www.cnbc.com/2022/11/30/alzheimers-drug-lecanemab-slows-cognitive-decline-in-dementia-fight.html"
    ampWebUrl: "https://www.cnbc.com/amp/2022/11/30/alzheimers-drug-lecanemab-slows-cognitive-decline-in-dementia-fight.html"
    cdnAmpWebUrl: "https://www-cnbc-com.cdn.ampproject.org/c/s/www.cnbc.com/amp/2022/11/30/alzheimers-drug-lecanemab-slows-cognitive-decline-in-dementia-fight.html"
    type: article
    provider:
      name: CNBC
      domain: cnbc.com
    quality: 82
    images:
      - url: "https://image.cnbcfm.com/api/v1/image/107158864-1669806496855-gettyimages-484332326-bb_fea-brainscan_108.jpeg?v=1669807708"
        width: 1024
        height: 683
        isCached: true
  - title: "Alzheimer's drug from Eisai and Biogen slows cognitive decline, side-effects in focus"
    excerpt: "SAN FRANCISCO, Nov 29 (Reuters) - An experimental Alzheimer's drug from Eisai (4523.T) and Biogen (BIIB.O) slowed cognitive decline in a closely watched trial but may carry a risk of serious side ..."
    publishedDateTime: 2022-11-30T14:56:00Z
    webUrl: "https://www.reuters.com/business/healthcare-pharmaceuticals/eisai-biogen-alzheimers-drug-slows-cognitive-decline-safety-some-becomes-focus-2022-11-30/"
    type: article
    provider:
      name: Reuters
      domain: reuters.com
    quality: 62
    images:
      - url: "https://www.reuters.com/resizer/wPhBmaGeWprDs_43Rc8rO6y48D0=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/4KT5OLQVG5LAFE33KAKPLQOAOY.jpg"
        width: 1200
        height: 628
        isCached: true
  - title: "Machine Learning Tools Helps Predict Alzheimer’s Progression"
    excerpt: "Researchers from Weill Cornell Medicine have used machine learning tools to identify the most accurate timelines and means of anticipating cognitive decline."
    publishedDateTime: 2022-11-30T13:29:00Z
    webUrl: "https://healthitanalytics.com/news/machine-learning-tools-helps-predict-alzheimers-progression"
    ampWebUrl: "https://healthitanalytics.com/news/amp/machine-learning-tools-helps-predict-alzheimers-progression"
    cdnAmpWebUrl: "https://healthitanalytics-com.cdn.ampproject.org/c/s/healthitanalytics.com/news/amp/machine-learning-tools-helps-predict-alzheimers-progression"
    type: article
    provider:
      name: Analytics
      domain: healthitanalytics.com
    quality: 59
    images:
      - url: "https://healthitanalytics.com/images/sized/2020-09-18-GettyImages-1154235081-e4b00c1efb9503a805928b101c78b499.jpg"
        width: 480
        height: 278
        isCached: true
  - title: "New Alzheimer’s drug can slow cognitive decline"
    excerpt: "Lecanemab is one of the first experimental dementia drugs to appear to slow the progression of cognitive decline. For patients in the early stages of Alzheimer’s, the drug slowed the rate of ..."
    publishedDateTime: 2022-11-30T23:56:00Z
    webUrl: "https://fox2now.com/news/missouri/new-alzheimers-drug-can-slow-cognitive-decline/"
    ampWebUrl: "https://fox2now.com/news/missouri/new-alzheimers-drug-can-slow-cognitive-decline/amp/"
    cdnAmpWebUrl: "https://fox2now-com.cdn.ampproject.org/c/s/fox2now.com/news/missouri/new-alzheimers-drug-can-slow-cognitive-decline/amp/"
    type: article
    provider:
      name: Fox2Now St. Louis
      domain: fox2now.com
    quality: 44
    images:
      - url: "https://fox2now.com/wp-content/uploads/sites/14/2022/11/snapshot-2022-11-30T175453.346.jpg?w=1280"
        width: 1280
        height: 720
        isCached: true
  - title: "Alzheimer's drug lecanemab slows cognitive decline but concerns linger"
    excerpt: "A drug called lecanemab is the first treatment that has been shown to slow cognitive decline in people with early Alzheimer’s disease. It also decreases plaques and tangles in the brain that are ..."
    publishedDateTime: 2022-11-30T12:34:00Z
    webUrl: "https://www.newscientist.com/article/2349153-alzheimers-drug-lecanemab-slows-cognitive-decline-but-concerns-linger/"
    type: article
    provider:
      name: New Scientist
      domain: newscientist.com
    quality: 24
    images:
      - url: "https://images.newscientist.com/wp-content/uploads/2022/11/30102827/SEI_135703799.jpg"
        width: 1200
        height: 800
        isCached: true
  - title: "New Alzheimer's Drug Reduces Cognitive Decline but May Cause Severe Side Effects, Study Finds"
    excerpt: "According to research published by the New England Journal of Medicine on Tuesday, the drug lecanemab slows cognitive decline. \"Lecanemab reduced markers of amyloid in early Alzheimer's disease ..."
    publishedDateTime: 2022-11-30T23:26:00Z
    webUrl: "https://people.com/health/new-alzheimers-drug-reduces-cognitive-decline/"
    type: article
    provider:
      name: People
      domain: people.com
    quality: 13
    images:
      - url: "https://people.com/thmb/E-Zihgp5UdCArXW3pdsRyteX-Pw=/1500x0/filters:no_upscale():max_bytes(150000):strip_icc():focal(1019x465:1021x467)/alzheimers-trial-dc6e24a5050c4d4d886d5c7558111ff0.jpg"
        width: 1500
        height: 1000
        isCached: true
  - title: "Alzheimer’s drug lecanemab has ‘moderate’ effect on cognitive decline, new trial data show"
    excerpt: "The phase 3 results, published Tuesday, showed a 27% slower rate of cognitive decline in recipients ... for the Centers for Medicare & Medicaid Services, and the Alzheimer’s Association called ..."
    publishedDateTime: 2022-12-01T01:03:00Z
    webUrl: "https://www.mcknights.com/news/clinical-news/alzheimers-drug-lecanemab-has-moderate-effect-on-cognitive-decline-new-trial-data-show/"
    type: article
    provider:
      name: McKnight's Long-Term Care News
      domain: mcknights.com
    quality: 0

secured: "5xtzUwf0W/KChyZfyvDIywQy02mDxNycGlVgAK+/nKGyrG9gd8Kv54GHtkhJ6eXq7m05PZw66mwEkeUav/7vHiZ85V2HUTFJBcaN760H5U7JMAXn5K9I0TwyLMOyLJ7ub3+tA78twurU6oA/jQqLadXd81EKYIkzG96ySrAITjCc0opUy4T0F5BZs6FxtYHg5v2er8yn+p3OSFtkZmiqo7DBWVnuf8RNg6DaseOCTxYRDCmQ9H4QGstfSORjrybpCeT3qa8AyDMdodGfE9htJZnlQnZnc963XYBVQBVAVqQAGfAiP0JrX4p0kpUdyKrfyuvcwL1uKLVtG/qL/ZpqqNHq8Jgw11p/D6Xd1DZThVc=;pxXhghpiCXHiUkzkIA74aQ=="
---

